Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Colleoni

Showing results (1-10 of 264) with videos related to

Pageof 27
Sort By:
The Lancet. Oncology|February 13, 2016
Neoadjuvant nab-paclitaxel in breast cancer: trial results and patient careMarco Colleoni
Expert Opinion on Drug Metabolism & Toxicology|January 26, 2010
LetrozoleSilvia Dellapasqua, Marco Colleoni
Therapeutic Advances in Medical Oncology|July 7, 2018
Optimal management of luminal breast cancer: how much endocrine therapy is long enough?Elisabetta Munzone, Marco Colleoni
Therapeutic Advances in Medical Oncology|January 4, 2020
Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancerEmilia Montagna, Marco Colleoni
Cancer Letters|January 18, 2017
Metronomics in the neoadjuvant and adjuvant treatment of breast cancerElisabetta Munzone, Marco Colleoni
Current Problems in Cancer|February 6, 2003
Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapyMarco Colleoni, Aron Goldhirsch
Onkologie|May 29, 2003
Adjuvant chemotherapy in breast cancer: back to the futureMarco Colleoni, Aron Goldhirsch
Breast (Edinburgh, Scotland)|October 1, 2013
Extended adjuvant chemotherapy in endocrine non-responsive diseaseMarco Colleoni, Elisabetta Munzone
Nature Reviews. Clinical Oncology|August 5, 2015
Clinical overview of metronomic chemotherapy in breast cancerElisabetta Munzone, Marco Colleoni
The Lancet. Oncology|December 24, 2013
Neoadjuvant chemotherapy for breast cancer: any progress?Marco Colleoni, Aron Goldhirsch
Pageof 27

Showing results (1-10 of 264) with videos related to

Sort By:
Pageof 27
The Lancet. Oncology|February 13, 2016
Neoadjuvant nab-paclitaxel in breast cancer: trial results and patient careMarco Colleoni
Expert Opinion on Drug Metabolism & Toxicology|January 26, 2010
LetrozoleSilvia Dellapasqua, Marco Colleoni
Therapeutic Advances in Medical Oncology|July 7, 2018
Optimal management of luminal breast cancer: how much endocrine therapy is long enough?Elisabetta Munzone, Marco Colleoni
Therapeutic Advances in Medical Oncology|January 4, 2020
Hormonal treatment combined with targeted therapies in endocrine-responsive and HER2-positive metastatic breast cancerEmilia Montagna, Marco Colleoni
Cancer Letters|January 18, 2017
Metronomics in the neoadjuvant and adjuvant treatment of breast cancerElisabetta Munzone, Marco Colleoni
Current Problems in Cancer|February 6, 2003
Adjuvant systemic therapies for patients with breast cancer: endocrine responsiveness and effects of chemotherapyMarco Colleoni, Aron Goldhirsch
Onkologie|May 29, 2003
Adjuvant chemotherapy in breast cancer: back to the futureMarco Colleoni, Aron Goldhirsch
Breast (Edinburgh, Scotland)|October 1, 2013
Extended adjuvant chemotherapy in endocrine non-responsive diseaseMarco Colleoni, Elisabetta Munzone
Nature Reviews. Clinical Oncology|August 5, 2015
Clinical overview of metronomic chemotherapy in breast cancerElisabetta Munzone, Marco Colleoni
The Lancet. Oncology|December 24, 2013
Neoadjuvant chemotherapy for breast cancer: any progress?Marco Colleoni, Aron Goldhirsch
Pageof 27